Results 181 to 190 of about 72,682 (275)
The Great Debate With IBD Biosimilars: Pro: Biosimilars Should Be Routinely Used as a First Line Biologic and May Be Switched From Reference Biologics. [PDF]
Limdi JK, Farraye FA.
europepmc +1 more source
openaire +5 more sources
Percepções sociais sobre o futuro da humanidade no planeta: um estudo na cidade de Piracicaba, SP
Vanessa Corrêa da Silva Bueno
openalex +2 more sources
Spanish Readers Skip Articles Regardless of Gender and Number Agreement. [PDF]
Serrano-Carot M, Angele B.
europepmc +1 more source
Switching from infliximab to biosimilar in inflammatory bowel disease: overview of the literature and perspective. [PDF]
Milassin Á, Fábián A, Molnár T.
europepmc +1 more source
La construcción histórica del concepto de fuerza centrípeta en relación con las dificultades de su aprendizaje [PDF]
Bibiloni, Lluís, Casadellà Reig, Josep
core +2 more sources
Clinical experience with infliximab biosimilar Remsima (CT-P13) in inflammatory bowel disease patients. [PDF]
Jahnsen J.
europepmc +1 more source

